RE:To Be?
Its still a year to grow the company. Even if we stay flat I'm buying. Below $4 is a gift. You make no mention of Highland or Wagners who still control a good market share in their segment. Recent pharma deals have yet to close and bear fruit. One old insider left to exit his position. Still algo games played with low volume volatility. As we saw last recently when this moves up it can happen fast. That move was simply on leaked news and I expect solid revenue growth to keep the momentum going once more parts of the company are up and running.